Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model is a research paper published in Journal for ImmunoTherapy of Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 51 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA138264
NCI NIH HHS
Grant: U01 CA212007
National Institutes of Health
Grant: 5R01CA138264-13
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
National Institutes of Health
Grant: 5U01CA212007-03
Integrating bioinformatics into multiscale models for hepatocellular carcinoma
FWCI
3.46
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo
Additional file 1 of Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo